Scientists call for more drugs, vaccines for multidrug-resistant TB

05/18/2010 | Reuters

Spending on research and development of drugs and vaccines for multidrug-resistant strains of tuberculosis should be increased as MDR-TB starts to advance in some countries, scientists said. Additional vaccines, treatments and diagnostic tests could reduce the global incidence of TB by 94% by 2050, they said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC